Pathways to complement activation during cardiopulmonary bypass.
- 10 November 1984
- Vol. 289 (6454) , 1251-1254
- https://doi.org/10.1136/bmj.289.6454.1251
Abstract
Complement activation was assessed in 34 patients undergoing cardiopulmonary bypass. Arterial concentrations of complement fragments Ba and C3d rose in all patients, the increase in Ba preceding that of C3d. At the same time as complement fragments were being generated the arterial neutrophil count fell. These findings suggest (a) that complement activation is initiated by the alternative pathway during cardiopulmonary bypass and (b) that complement activation mediates loss of neutrophils during bypass. Complement mediated loss of neutrophils during the analogous setting of haemodialysis is the result of leucosequestration in the pulmonary vasculature. During cardiopulmonary bypass the lungs are out of circuit, so that activated leucocytes may sequester in other target organs. This may be an aetiological factor in the multi-organ failure occasionally seen after uneventful cardiopulmonary bypass.This publication has 20 references indexed in Scilit:
- Complement activation during cardiopulmonary bypass: quantitative study of effects of methylprednisolone and pulsatile flow.BMJ, 1983
- Clinical application of a new nephelometric technique to measure complement activation.Journal of Clinical Pathology, 1983
- Complement and the damaging effects of cardiopulmonary bypass.Thorax, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.Journal of Clinical Investigation, 1977
- Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone.Journal of Clinical Investigation, 1975
- Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.Journal of Clinical Investigation, 1975
- INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEMThe Journal of Experimental Medicine, 1974
- Depression of immunologic surveillance by pump-oxygenation perfusionJournal of Surgical Research, 1969